tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Vanda Pharmaceuticals Inc. (GB:0LKB)
LSE:0LKB
0LKB
Vanda
Stock Analysis
Analyst Forecasts
Technical Analysis
Chart
Earnings
Dividends
Ownership
Financials
News & Insights
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding GB:0LKB?
Track your performance easily
Link Broker

Vanda (0LKB) Stock News & Sentiment

0 Followers
Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results
Premium
Press Releases
Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results
2M ago
VNDA
VNDA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VNDA Earnings this Week: How Will it Perform?
2M ago
VNDA
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
Premium
Press Releases
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
4M ago
VNDA
Vanda Pharmaceuticals Considers Cycle Group’s Preliminary Interest
Premium
Company Announcements
Vanda Pharmaceuticals Considers Cycle Group’s Preliminary Interest
4M ago
8K
VNDA
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
Premium
Press Releases
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
4M ago
VNDA
Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders
Premium
Press Releases
Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders
4M ago
VNDA
Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
Premium
Press Releases
Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
5M ago
VNDA
More VNDA News >

0LKB News on the Web

VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis
Zacks
Neutral
VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis
Yahoo Finance
Neutral
Novo sinks on obesity drug results; Sanofi reveals anticipated MS data
BioPharma Dive
Neutral
Validea Kenneth Fisher Strategy Daily Upgrade Report - 9/20/2024
Validea
Neutral
FDA declines approval of Vanda’s gastroparesis treatment
Pharmaceutical Technology
Bearish
Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today
The Motley Fool
Neutral
Why Is Vanda Pharmaceuticals Stock Falling In Pre-market?
rttnews
Neutral
FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis
Yahoo Finance
Neutral

News Score - Last 7 Days

Negative
GB:0LKB
Sector Average
Media Buzz
This Week5 articles
Weekly Average2.75 articles
News Sentiment
This Week0%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0LKB’s Media Buzz Sentiment?
5 articles about GB:0LKB were published this week. In an average week, 2.75 articles are published.
    What is GB:0LKB’s weekly average amount of articles?
    In an average week, 2.75 articles about GB:0LKB are published.
      What is GB:0LKB’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      WVEWave Life Sciences
      ZVRAZevra Therapeutics
      IDYAIDEAYA Biosciences
      VTYXVentyx Biosciences
      HRMYHarmony Biosciences Holdings
      Showing the stocks with the most bullish news sentiment over the past week

      Become an Expert with TipRanks Premium

      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis
      Subscribe NowSee Plans & Pricing